BFSG »

Homology Medicines shares owned by BFSG

Quarter-by-quarter ownership of Homology Medicines shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by BFSG

Quarter filed Position value Share count Share price at filing
2023-12-31 $122 200 0.61

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Vanguard World Energy Etf (VDE)
Ishares Gold Tr Ishares New (IAU)
Church & Dwight (CHD)
CSX Corporation (CSX)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Vanguard Bd Index Fds Short Trm Bond (BSV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Raytheon Technologies Corp (RTX)
Exxon Mobil Corporation (XOM)
Costco Wholesale Corporation (COST)

View all positions for BFSG

Top funds holding Homology Medicines

5AM Venture Management
Vanguard Group
Newtyn Management
George Kaiser Family Foundation
ADAR1 Capital Management
Bank of America Corporation
Tudor Investment Corporation
Citadel Advisors
Barclays
Franklin Resources
American Investment Services
Virtu Financial
Schechter Investment Advisors
Goldman Sachs Group
Jane Street

View all funds holding Homology Medicines